Detalhe da pesquisa
1.
Optimal timing of PD-1 blockade in combination with oncolytic virus therapy.
Semin Cancer Biol
; 86(Pt 3): 971-980, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34033895
2.
A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study.
Cancer Immunol Immunother
; 72(6): 1405-1415, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36445410
3.
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
Proc Natl Acad Sci U S A
; 117(2): 1119-1128, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31888983
4.
Metastasectomy following incomplete response to high-dose interleukin-2.
J Surg Oncol
; 117(4): 572-578, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29165819
5.
Avelumab and other recent advances in Merkel cell carcinoma.
Future Oncol
; 13(30): 2771-2783, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28976209
6.
Misexpression of ptf1a in cortical pyramidal cells in vivo promotes an inhibitory peptidergic identity.
J Neurosci
; 35(15): 6028-37, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25878276
7.
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival.
J Immunother Cancer
; 12(4)2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38599661
8.
Breaking the barriers in cancer care: The next generation of herpes simplex virus-based oncolytic immunotherapies for cancer treatment.
Mol Ther Oncolytics
; 31: 100729, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37841530
9.
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer.
J Immunother Cancer
; 11(7)2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433716
10.
A Water-Soluble Antibiotic in Rhubarb Stalk Shows an Unusual Pattern of Multiple Zones of Inhibition and Preferentially Kills Slow-Growing Bacteria.
Antibiotics (Basel)
; 10(8)2021 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439001
11.
Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma.
J Clin Oncol
; 39(34): 3829-3838, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464163
12.
Generation and validation of recombinant herpes simplex type 1 viruses (HSV-1) using CRISPR/Cas9 genetic disruption.
Methods Enzymol
; 635: 167-184, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32122544
13.
Oncolytic Herpes Simplex Virus Encoding IL12 Controls Triple-Negative Breast Cancer Growth and Metastasis.
Front Oncol
; 10: 384, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32266155
14.
Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response.
Nat Cancer
; 1(9): 923-934, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476408
15.
Two roads for oncolytic immunotherapy development.
J Immunother Cancer
; 7(1): 26, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30709365
16.
Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade.
Oncoimmunology
; 8(4): e1571390, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30906668
17.
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma.
Oncoimmunology
; 8(7): 1591875, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31143509
18.
Multi-parametric flow cytometry staining procedure for analyzing tumor-infiltrating immune cells following oncolytic herpes simplex virus immunotherapy in intracranial glioblastoma.
J Biol Methods
; 6(2)2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31123687
19.
Oncolytic Immunotherapy.
Surg Oncol Clin N Am
; 28(3): 419-430, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31079797
20.
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1.
J Immunother Cancer
; 7(1): 214, 2019 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399043